Transanal endoscopic microsurgery has become an established method of transanally excising rectal tumors. It uses a closed, airtight system that provides constant rectal distension, improved visibility, and longer reach than conventional instrumentation. Virtually any rectal adenoma and properly selected cancers can be removed with this technique. Transanal endoscopic microsurgery excision of cancers requires that strict selection criteria be satisfied and is best suited for Ti cancers. Transanal endoscopic microsurgery should not replace low anterior resection or abdominoperineal resection for those cancers that have either deep penetration into the rectal wall or lymph node metastases. This procedure is safe, is associated with minimal complications, and most patients can be treated on an outpatient basis. Complications include bleeding, urinary retention, temporary soilage, and inadvertent entry into the peritoneal cavity. Once transanal endoscopic microsurgery has been mastered, it may become the technique of choice for locally excising rectal neoplasms. pioneered by Professor Gerhard Buess (Germany) and manufactured by the Richard Wolf Company, transanal endoscopic microsurgery (TEM) represents a unique blend of the old and the new. Although transanal excision of rectal neoplasms has been an accepted procedure for decades, surgeons have been restricted by the suboptimal exposure and limited reach of conventional instrumentation.
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TEM is yet another tool in the armamentarium of surgeons who practice transanal excision. To achieve acceptable results and not jeopardize proper patient care, the selection criteria that were enumerated years ago must still be followed. In this respect, TEM does not constitute anything new. In fact, having the technology is not license to use it inappropriately. However, by virtue of its longer reach, better exposure, and superior optics, TEM joins the category of other minimally invasive surgical procedures.
Lesions in the mid and upper rectum, which heretofore may have required a laparotomy and radical resection for removal, may now be addressed with a less invasive approach. As such, diminished postoperative pain, shorter recovery, and a faster return to normal function are real and attainable goals.1-4 This is especially true considering the high morbidity associated with the Mason and Kraske procedures, where wound infection and fecal fistulas can be debilitating for the patient. This chapter outlines the indications, equipment, technique, and results of TEM as it is currently practiced.
Transanal Endoscopic Microsurgery Utilization
Currently, approximately 430 TEM systems are in use worldwide. As expected, TEM is most frequently used in the United Kingdom and the European continent, where approximately 150 units are present in Germany, 48 in the United Kingdom and 32 in Italy. In Japan and Southeast Asia, approximately 110 units are in use. In the United States, 45 systems are functional; however, usage has been slow to catch on for a variety of reasons, one of which is the lack of a specific Centers for Medicare and Medicaid Services procedure code for this technique.
Indications
Virtually any adenoma regardless of size, location, and degree of circumferential involvement can be removed with TEM instrumentation. As long as the lesion can be reached and completely visualized with a rigid scope, it can be removed. If the lesion extends around the rectosigmoid junction and cannot be visualized in its entirety, then perhaps TEM is not the best approach. Lesions that encompass 360 degrees of the rectal circumference can be successfully removed and intestinal continuity reestablished by a transanal hand-sewn end-to-end anastomosis.
Proper patient selection must be followed when TEM is used to remove cancers with curative intent. These selection criteria include superficial penetration (preoperative staging with endorectal ultrasound is essential), well-to-moderately-well differentiation, lack of lymphovascular invasion, lack of perineural invasion, and perhaps no mucinous component. If these criteria are not satisfied, the risk of lymph node metastases is increased and TEM should not be considered since the extramural component of the cancer cannot be addressed.5 '6 Large size (greater than 3 to 4 cm) has been considered a relative contraindication for transanal excision of rectal cancers, simply because adequate exposure has been difficult to obtain with bivalve retractors and other conventional equipment that risk the possibility of residual tumor. TEM, however, circumnavigates the size issue as visualization and exposure of the entire lesion is less of a problem and complete removal with negative margins is more likely.
Transanal excision can be considered in other instances, although cure may not be possible or may not be as readily obtained. Clearly, palliation of a tumor can be considered when diffuse systemic metastases are present. Unfortunately, most primary tumors in these instances are large and may not be amenable to transanal excision.
TEM may be considered if the patient is medically unfit to undergo conventional surgery because of multiple comorbid factors. If a patient is unwilling to undergo conventional surgery or stoma formation because of fears regarding changes in body image, then transanal excision can be combined with radiation therapy and chemotherapy.7 However, a large number of patients have not been treated in this fashion, and consequently, results regarding cure are more suspect. Further studies are needed to determine whether the oncologic results are acceptable.
If transanal excision, regardless of technique, is undertaken with curative intent, endorectal ultrasound may select those tumors that are most amenable to this approach. Our practice is to proceed directly with TEM resection for patients with a UT1 tumor; however, it is important to inform the patient that additional treatment may be required if the final pathologic assessment of the lesion reveals that it is more deeply invasive.
If ultrasound reveals that the tumor has partially invaded the muscularis propria (UT2) and the lesion is small, TEM can still be undertaken with a comparison of pathologic and sonographic staging. If ultrasound has overstaged the lesion, TEM resection should be curative. If the endorectal ultrasound shows that the tumor has deeply penetrated, but has not completely invaded through the muscularis propria, and a proctoscopic examination shows that the tumor is large, we will proceed promptly with a radical resection of the tumor, usually with a transabdominal approach. If ultrasound reveals that the lesion is penetrating into the extrarectal fat, or lymph nodes in the vicinity are suggestive, we recommend preoperative chemoradiation and then radical surgery.
Extended indications for the TEM instrumentation include rectopexy for rectal prolapse. Although experience with this technique is limited, it theoretically does address the anatomic lack of fixation of the rectum to the presacral space and hence, holds promise. TEM is used to make a posterior rectotomy, and dissection is undertaken through the mesorectal fat down to the presacral fascia. Transfixing sutures are then placed transmurally above the rectotomy, and these sutures are then placed through the presacral fascia. In this way, the rectum is anchored to the connective tissue and the rectotomy is then closed. Other extended indications include lysis of anastomotic or fibrotic strictures of the rectum, endorectal advancement flaps to close the internal opening of high fistulas, and full-thickness biopsies. Equipment TEM uses a closed endoscopic system that allows for the instillation and retention of carbon dioxide gas. This creates constant rectal distension that facilitates the exposure and visualization of the lesion, excision of the tumor, control of bleeding, and subsequent closure of the wound defect. Other distinguishing features of TEM are the long reach of the instruments and the unique stereoscopic image that provides magnification.
The intrarectal pressure is set at a desired level (usually 10 to 15 cm H20). A combined multifunctional endosurgical unit automatically regulates suction, irrigation, intrarectal pressure, and gas insufflation ( Figure 1 ) so that the pressure is maintained at a constant level.
The beveled operating rectoscopes are approximately 4 cm in diameter (Figure 2 ). Since the beveled end of the scope must face downward at the lesion, patients are variably positioned, depending upon the location of the lesion along the anteriorposterior dimensions of the rectal wall: * Patients with an anteriorly located lesion should be placed in the prone position and the legs spread apart to permit access to the perineum. After the legs are placed and secured on long arm boards, the foot of the table is dropped. * For a posteriorly located lesion, the patient is placed in the lithotomy position. * If the lesion is laterally located, the patient is placed in the appropriate lateral decubitus position. The end of the rectoscope is covered with a sealed face piece that has air-tight rubber seals and sealed working ports through which are inserted the long-shafted instruments necessary for the dissection (Figures 3 and 4) . The suction catheter can be electrified, which will allow bleeding vessels to be coagulated while the blood is being aspirated. Similarly, tissue graspers can be electrified for the control of a bleeding vessel.
Vision is obtained through a binocular stereoscopic eyepiece that may take some time getting used to, especially for the novice. However, it does provide a nice depth of vision and magnification of the operative field. An accessory scope may be inserted for video imaging and viewing by surgical assistants, students, and residents. The binocular eyepiece provides 6x magnification, has a 50-degree downward view, and a 75-degree lateral field of view. In contrast, the accessory scope has a 40-degree downward view and a reduced lateral field of view. Because of this discrepancy, the image seen through the accessory scope and Transanal Endoscopic Microsurgery the video monitor is narrower in its scope and may appear as though the surgeon is going off of the field. The complete set-up is shown in Figure 5 .
Preoperative Workup
If a rectal lesion is found during proctosigmoidoscopy, then a colonoscopy or a flexible sigmoidoscopy with a contrast enema must be performed to rule out synchronous lesions located elsewhere within the colon. If a patient is referred to the surgeon for TEM after undergoing a flexible fiberoptic examination, a rigid proctosigmoidoscopy must still be performed to assess the level of the lesion in the rectum. Furthermore, it is mandatory that the surgeon visualizes the lesion to assess whether it can be removed with TEM instrumentation. The exact location must also be determined, which will dictate how the patient is positioned on the operative table.
Endorectal ultrasound is essential to evaluate how deep a malignant lesion has penetrated. Ultrasound is also recommended for staging large villous adenomas, since these larger lesions may contain an unsuspected cancer. Distant metastases should be ruled out by using the appropriate radiographic test (computed tomography, magnetic resonance imaging, or ultrasound).
If the patient is scheduled for surgery, any comorbid medical conditions should be addressed. Informed consent should be obtained with the following considerations in mind. If bleeding is encountered or if a lesion cannot be removed, conversion to a transabdominal approach may be necessary. In addition, for anteriorly located lesions, one may inadvertently enter the peritoneal cavity. Although this may be repaired with transanal suturing techniques, conversion to an abdominal approach may be required.
When the operation is for cancer, it is imperative for the patient to understand that TEM is being performed with an "excisional biopsy" mentality. This means that following excision, the lesion will be assessed histologically for any adverse features that would suggest that lymph node metastases may be present to a higher statistical degree and, if so, further therapy with either surgery or chemoradiation may be needed.8 A formal bowel preparation is mandatory in order to ensure visibility and reduce the risk of infection. This may be accomplished with either oral cathartics, enemas, or lavage solutions. General or regional anesthesia is required. Although most TEM resections can be performed on an outpatient basis, an overnight stay may be required for some patients for anesthetic-related nausea, urinary retention, or observance for bleeding. Pain is generally not an issue and should not require parenteral medications.
Technique
The rectoscope is inserted under direct vision to the lesion, at which point it is fixed to the operating room table with the double-jointed supporting arm. Repositioning of the rectoscope is frequently required during the course of the operation to maintain positioning of the lesion within the visual field. Once the gas lines have been connected and the instruments inserted, the rectal pressure should be monitored to assess for the presence of a leak. If the pressure cannot be maintained, an assessment of the complete set-up is required to identify the source for carbon dioxide leak.
The resection is begun by the placement of cautery points around the circumference of the lesion. For adenomas, a 5-mm zone of normal surrounding mucosa is chosen. For larger adenomas that may contain an occult cancer and for known malignancies, a 1-cm zone of normal mucosa is mapped out around the lesion. The excision is.performed with the needle-tip cautery. Caution should be exercised for anterior lesions, where an inadvertent entry into the peritoneal cavity may occur. The location of the anterior peritoneal reflection varies and may be quite low, especially in elderly women. For this reason, a full-thickness excision of an anterior lesion may be approached, preferably with a transabdominal radical operation. 
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After the lesion is removed, the wound is irrigated with saline or Betadine solution and is then transversely closed with monofilament sutures of short length ( Figure 6 ). These sutures are started and finished with metallic silver shots, since knot tying is not generally possible within the small confines of the rectal vault.
If the histologic review of the lesion shows a deeply penetrating carcinoma, further therapy is required because of the possibility of lymph node metastases. If this is the case, one should allow sufficient time for the TEM wound to heal before proceeding with a low anterior resection or abdominoperineal resection. If the operation is performed too soon following TEM, the suture line may open during the course of rectal mobilization, thereby jeopardizing possible tumor control and allowing spillage of fecal contents.
Results
Digital rectal examination and rigid proctosigmoidoscopy are performed at 3, 6, and 9 months after TEM. A follow-up colonoscopy should be performed at the 1-year mark. Although rectal ultrasound may be combined with proctosigmoidoscopy, caution should be exercised in interpreting the results because tissue planes will have been altered as a result of the excision. Consequently, no definitive decision should be made based upon the first examination. With serial ultrasound examinations, however, one can find enlarging hypoechoic nodules either within the rectal wall or Figure 6 . Suturing the defect is performed in a rightto-left direction. The suture is started and finished with a silver shot. the rectal mesentery that suggest tumor recurrence. Ultrasound-guided needle techniques can be used to biopsy such recurrences.
Complications, which are relatively infrequent, include entry into the peritoneal cavity, conversion to laparotomy, fecal soilage, fever, wound dehiscence, urinary dysfunction, and fistulas. In my experience, soilage has occurred in only 2% of patients and has generally been of short duration.
TEM has been used at Rush University Medical Center since 1991. Between 1991 and 2003, 215 cases have been undertaken at an annual rate of about 20 to 30 cases. The average patient age is 64.9 years, and the average distance from the dentate line has been 7 cm. The mean estimated blood loss has been approximately 30 mL and has exceeded 50 mL in only 13% of cases. The mean operative time has been 76 minutes, 17% of cases have been less than 30 minutes in duration and only 5% longer than 2 hours.
During this time, 99 adenomas were excised, 104 cancers were removed, and the remainder of the lesions consisted of gastrointestinal stromal tumors and carcinoids. For the adenomas, the mean distance was 6.8 cm, the mean estimated blood loss was 24 mL, the mean operative time was 72 minutes, and the mean size of the lesion was 3.4 cm in maximum diameter. For the cancers, the mean distance from the dentate line was 6.7 cm, the mean estimated blood loss was 43 mL, the mean operative time was 91 minutes, and the mean size was 3.4 cm in maximum diameter.
The number of new rectal cancers treated by all means over the last 8 years has remained fairly stable at 25 to 40 cases per year, and the use of TEM has remained constant as well. This reflects our policy of strict patient selection when TEM is used for cure. We have used TEM to treat 48 patients with pathologic Ti cancers. Forty-six percent of the lesions were located between 5 and 10 cm, and 25% were higher than 10 cm. Forty-four percent of the cancers were between 2 and 4 cm in maximum diameter, while 13% were larger than 4 cm.
With a mean follow-up of 2.6 years, the recurrence rate has been 10.4%. Of the recurrences, four were salvaged with radical surgery, and one was treated with simple fulguration because of advanced age. No cancer related deaths occurred during this follow-up period, and we attribute this to our stringent follow-up program. Tables 1 and 2 list the oncologic results and complications from various centers that use TEM.1,3,4 [9] [10] [11] [12] Conclusions TEM has proven to be a safe technique for the treatment of adenomas and selected rectal cancers. Strict patient selection is essential for treating cancers to avoid compromising cure rates and the patient's well-being.
An intense, didactic course with hands-on experience is recommended prior to a surgeon em-barking on this technique. There are specific critical technical lessons for the TEM novice. Crossover of instruments should be avoided, as this will hinder the excision and subsequent wound closure. The instruments should be inserted and manipulated in parallel. The needle should be carefully passed from instrument to instrument to avoid inadvertent dropping out of sight, as additional time will be required to recover the needle. One should reconsider using TEM for distal lesions and instead use conventional instrumentation. The reason for this is twofold. First, the lower lip of the scope bevel may slip outside of the anal canal causing carbon dioxide to leak and the operative field to collapse. Second, operating near the hemorrhoidal veins may result in blood loss that can be frustrating for the TEM novice.
The ability to trouble-shoot even seemingly minor issues is paramount. If the operative field has collapsed and distensibility is not maintained, one must be able to inspect the common areas where leakage of carbon dioxide gas can occur. This problem can stem from kinking of the gas line, cracks within the rubber caps or sleeves, and failure to properly lock the scope, face piece, or accessory scope in place.
The surgeon should start with small lesions and advance to larger lesions only after comfortable familiarity with the equipment has been established. It is also recommended that only one case per day be undertaken, preferably the last case of the day. In this way, potential delays encountered with equipment set-up, troubleshooting problems, and mastering the technique will not impede the established and scheduled flow of the operating rooms.
